Background Atopic dermatitis (AD) is a common and chronic inflammatory skin disease of
type 2 immunity. Keratinocyte-derived cytokines, including thymic stromal lymphopoietin …

Background Epidermal barrier dysfunction has been recognized as a critical factor in the
initiation and exacerbation of skin inflammation, particularly in patients with atopic dermatitis …

Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with elevated levels
of allergen‐specific IgE. Although thymic stromal lymphopoietin (TSLP) and interleukin‐17A …

Atopic dermatitis (AD) often precedes asthma and food allergy, indicating that epicutaneous
sensitization to allergens may be important in the induction of allergic responses at other …

Atopic dermatitis (AD) is a chronic inflammatory skin disease in which T‐helper type 2 (Th2)‐
type immune responses are dominant. Th2 cytokine, interleukin (IL)‐33 and thymic stromal …

Atopic dermatitis often precedes the development of asthma, a phenomenon known as
“atopic march”. An important role of allergen sensitization developed through barrier …

Background A major route of sensitization to food allergen is through an impaired skin
barrier. IL-33 and thymic stromal lymphopoietin (TSLP) have both been implicated in …

Atopic dermatitis (AD), a skin disease characterized by pruritus and chronic inflammation,
results from a complex interplay between environmental and genetic factors. Thymic stromal …

Although atopic dermatitis (AD) is the initial step of the “atopic march”, a progression from
AD to asthma, the underlying mechanism remains unknown. Selective expression of IL-13 in …

Both thymic stromal lymphopoietin (TSLP) and IL‐13 are essential cytokines for the
development of allergic inflammation. However, a causal link between TSLP and IL‐13 has …